DOCSLIB.ORG

A Dual Role for REV-ERB Alpha in Th17 Cell Mediated Immune Response

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Dual Role for REV-ERB Alpha in Th17 Cell Mediated Immune Response UNIVERSITY OF CALIFORNIA, SAN DIEGO A Dual Role for REV-ERB alpha in Th17 Cell Mediated Immune Response A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biology by Fang-Chen Chang Committee in charge: Professor Ye Zheng, Chair Professor Jack Bui Professor Christopher K. Glass Professor Lifan Lu Professor Clodagh O’Shea Professor Elina Zuniga 2016 Copyright Fang-Chen Chang, 2016 All rights reserved The dissertation of Fang-Chen Chang is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair University of California, San Diego 2016 iii DEDICATION To my parents, for the opportunities they afforded me, and their unwavering support. And to Edmond, who spent many beautiful weekend afternoons waiting in the Salk parking lot. iv EPIGRAPH First, there is a mountain, then there is no mountain, then there is. —Traditional Buddhist saying, via Donovan (1967) v TABLE OF CONTENTS SIGNATURE PAGE .............................................................................................. iii DEDICATION ........................................................................................................ iv EPIGRAPH ............................................................................................................ v TABLE OF CONTENTS ........................................................................................ vi LIST OF FIGURES .............................................................................................. viii LIST OF TABLES .................................................................................................. x ACKNOWLEDGEMENTS ..................................................................................... xi VITA ..................................................................................................................... xii ABSTRACT OF THE DISSERTATION ................................................................ xiii Chapter One: Introduction ..................................................................................... 1 1.1 Th17 cells ..................................................................................................... 1 1.1.1 CD4+ T helper cells ............................................................................... 1 1.1.2 Th17 effector function and cytokine production ..................................... 3 1.1.3 Transcriptional regulation of Th17 differentiation .................................. 4 1.1.4 The role of Th17 cells in multiple sclerosis ............................................ 6 1.2 REV-ERBS .................................................................................................. 8 1.2.1 Nuclear hormone receptors ................................................................... 8 1.2.2 REV-ERBs ............................................................................................. 8 1.2.3 Endogenous and synthetic REV-ERB ligands ..................................... 10 1.2.4 Regulation of the circadian rhythm ...................................................... 11 1.2.5 Regulation of metabolism .................................................................... 12 1.2.6 Regulation of immune functions .......................................................... 14 1.3 Figures ....................................................................................................... 16 Chapter 2: Material and Methods ........................................................................ 18 2.1 Mice ........................................................................................................... 18 2.2 In vitro CD4 T cell differentiation ............................................................... 18 2.3 Flow cytometry .......................................................................................... 19 2.4 Reverse transcription and quantitative PCR ............................................. 20 2.5 Western blot .............................................................................................. 20 2.6 Retroviral transduction .............................................................................. 21 2.7 Dual luciferase reporter assay .................................................................. 21 vi 2.8 DNA binding assay ................................................................................... 21 2.9 Chromatin Immunoprecipitation ................................................................ 22 2.10 ChIP-sequencing .................................................................................... 22 2.11 RNA-sequencing and data analysis ........................................................ 23 2.12 EAE models ............................................................................................ 23 2.13 Histology analysis ................................................................................... 24 2.14 SR9009 treatment ................................................................................... 25 Chapter 3: Identification of REV-ERBa as a novel regulator in Th17 differentiation ............................................................................................................................. 27 3.1 Results ....................................................................................................... 27 3.2 Tables and Figures .................................................................................... 32 Chapter 4: The functional role of REV-ERBa in Th17 cell mediated autoimmune response .............................................................................................................. 44 4.1 Results ....................................................................................................... 44 4.2 Tables and Figures ................................................................................... 48 Chapter 5: In vitro and in vivo characterizations of REV-ERBa deficiency .......... 56 5.1 Results ....................................................................................................... 56 5.2 Tables and Figures .................................................................................... 59 Chapter 6: Discussion ......................................................................................... 65 6.1 Summary of findings ................................................................................. 65 6.3 Bridging the gain and loss of function phenotypes .................................... 68 6.4 Conclusion ................................................................................................. 72 6.5 Figures ....................................................................................................... 73 References .......................................................................................................... 76 vii LIST OF FIGURES Figure 1.1 Effector CD4+ T cell lineages .............................................................. 16 Figure 1.2 REV-ERBs and RORs play essential and opposing roles in the regulation of the molecular clock ................................................................... 17 Figure 3.1 REV-ERBa is up-regulated in Th17 cells ............................................ 32 Figure 3.2 REV-ERBa is up-regulated in human Th17 cells ................................ 33 Figure 3.3 Ectopic REV-ERBa expression inhibits Th17 differentiation ............... 34 Figure 3.4 REV-ERBs inhibit RORγt-dependent IL-17A expression .................... 35 Figure 3.5 Analysis of different REV-ERBα domains that are involved in repression of IL-17A expression .................................................................... 36 Figure 3.6 REV-ERBa over expression inhibits the expression of Th17 signature genes ............................................................................................................. 37 Figure 3.7 REV-ERBa directly inhibits IL17a expression ..................................... 38 Figure 3.8 Figure 2.8 REV-ERBa binds to a RORE within the il17a locus ........... 39 Figure 3.9 Figure 2.9 REV-ERBa binds to the endogenous Il17a locus ............... 40 Figure 3.10 REV-ERBa binds to the endogenous Il17a locus .............................. 41 Figure 3.11 REV-ERBa and RORgt compete for binding to the Il17a locus ......... 42 Figure 4.1 Doxycycline induces transgenic REV-ERBα expression in vivo, but does not affect EAE disease progression ..................................................... 48 Figure 4.2 In vivo induction of REV-ERBa expression in Th17 cells suppresses EAE disease progression .............................................................................. 49 Figure 4.3 Doxycycline treatment does not affect homing of transferred CD4+ T cells ............................................................................................................... 50 Figure 4.4 REV-ERB agonist SR9009 inhibits in vitro Th17 differentiation .......... 51 Figure 4.5 REV-ERB agonist SR9009 inhibits in vitro human Th17 differentiation52 Figure 4.6 REV-ERB agonist SR9009 enhances NCoR recruitment to the Il17a locus .............................................................................................................. 53 Figure 4.7 Treatment with REV-ERB agonist SR9009 suppresses EAE progression .................................................................................................... 54 Figure 4.8 Treatment with REV-ERB agonist SR9009 prevents relapse
Load more

Recommended publications
  • The Ins and Outs of Circadian Timekeeping Steven a Brown* and Ueli Schibler†
    gd9507.qxd 11/10/1999 12:14 PM Page 588 588 The ins and outs of circadian timekeeping Steven A Brown* and Ueli Schibler† Recent research in Drosophila and in mammals has generated The mechanism by which light signals entrain the clock is fascinating new models for how circadian clocks in these another topic of intense interest, and will be our other focus. organisms are reset by light and how these clocks, in turn, direct circadian outputs. Though light perception by the central clock is Central clock mechanisms: a brief summary ocular in mammals, it probably proceeds via a mechanism In all cases examined to date, circadian clocks have been separate from traditional visual transduction. In Drosophila, one cell-autonomous: a single cell can generate and maintain mechanism is non-ocular and is in fact present in many different self-sustained circadian oscillations. The molecular basis tissues. In both organisms, the cryptochrome family of for these rhythms may rely on a negative feedback loop in photoreceptor-like molecules plays a role in the circadian clock, which clock proteins negatively regulate their own abun- though their function is incompletely understood. Moreover, dance or activity. This regulation may occur both at the although a master clock resides in the brain, a functional clock transcriptional and at the post-transcriptional level. For appears to reside in most cells of the body. In these tissues, at example, in the bread mold Neurospora crassa, the Fre- least some output genes are controlled at the transcriptional quency protein negatively regulates its own transcription level directly by clock proteins; others appear to be regulated by by interfering with the ability of the White-collar-1 and cascades of circadian transcription factors.
    [Show full text]
  • Distinct Patterns of Period Gene Expression in the Suprachiasmatic Nucleus Underlie Circadian Clock Photoentrainment by Advances Or Delays
    University of Massachusetts Medical School eScholarship@UMMS Neurobiology Publications and Presentations Neurobiology 2011-10-11 Distinct patterns of Period gene expression in the suprachiasmatic nucleus underlie circadian clock photoentrainment by advances or delays William J. Schwartz University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/neurobiology_pp Part of the Neuroscience and Neurobiology Commons Repository Citation Schwartz WJ, Tavakoli-Nezhad M, Lambert CM, Weaver DR, de la Iglesia HO. (2011). Distinct patterns of Period gene expression in the suprachiasmatic nucleus underlie circadian clock photoentrainment by advances or delays. Neurobiology Publications and Presentations. https://doi.org/10.1073/ pnas.1107848108. Retrieved from https://escholarship.umassmed.edu/neurobiology_pp/114 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Neurobiology Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Distinct patterns of Period gene expression in the suprachiasmatic nucleus underlie circadian clock photoentrainment by advances or delays William J. Schwartza,1, Mahboubeh Tavakoli-Nezhada, Christopher M. Lambertb, David R. Weaverb, and Horacio O. de la Iglesiac,1 Departments of aNeurology and bNeurobiology, University of Massachusetts Medical School, Worcester, MA 01655; and cDepartment of Biology, University of Washington, Seattle, WA 98195 Edited by Michael Rosbash, Howard Hughes Medical Institute, Waltham, MA, and approved September 9, 2011 (received for review May 19, 2011) The circadian clock in the mammalian hypothalamic suprachias- and Per3) genes is activated. PER proteins accumulate in the matic nucleus (SCN) is entrained by the ambient light/dark cycle, cytoplasm, are regulated through their phosphorylation and their which differentially acts to cause the clock to advance or delay.
    [Show full text]
  • Stat4 Consensus and Mutant Oligonucleotides
    SANTA CRUZ BIOTECHNOLOGY, INC. Stat4 Consensus and Mutant Oligonucleotides BACKGROUND PRODUCT Electrophoretic mobility shift assays (EMSAs), also known as gel shift assays, Stat4 CONSENSUS OLIGONUCLEOTIDE: sc-2569 provide a relatively straightforward and sensitive method for studying bind- ■ binding site for Stat4 (3) ing interactions between transcription factors and consensus DNA binding elements. For such studies, DNA probes are provided as double-stranded 5’ — GAG CCT GA T TTC CCC GAA AT G ATG AGC TAG — 3’ oligonucleotides designed with 5' OH blunt ends to facilitate labeling to high 3’ — CTC GGA C T A AAG GGG CTT TA C TAC TCG ATC — 5’ specific activity with polynucleotide kinase. These are constructed both with Stat4 MUTANT OLIGONUCLEOTIDE: sc-2570 specific DNA binding consensus sequences for various transcription factors ■ identical to sc-2569 with the exception of a “CCC” “TTT” substitution in and as control or “mutant” probes in which one or more nucleotides mapping → the Stat4 binding motif (3) within the consensus binding site has been substituted. 5’ — GAG CCT GA T TTC TTT GAA AT G ATG AGC TAG — 3’ REFERENCES 3’ — CTC GGA C T A AAG AAA CTT TA C TAC TCG ATC — 5’ 1. Dignam, J.D., et al. 1983. Accurate transcription initiation by RNA poly- merase II in a soluble extract from isolated mammalian nuclei. Nucleic SELECT PRODUCT CITATIONS Acids Res. 11: 1475-1489. 1. Ahn, H.J., et al. 1998. Requirement for distinct Janus kinases and STAT 2. Murre, C., et al. 1991. B cell- and myocyte-specific E2-box-binding factors proteins in T cell proliferation versus IFN-g production following IL-12 contain E12/E47-like subunits.
    [Show full text]
  • GATA3 As an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: a Study with a Review of the Literature
    diagnostics Article GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature Patrizia Querzoli 1, Massimo Pedriali 1 , Rosa Rinaldi 2 , Paola Secchiero 3, Paolo Giorgi Rossi 4 and Elisabetta Kuhn 5,6,* 1 Section of Anatomic Pathology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44124 Ferrara, Italy; [email protected] (P.Q.); [email protected] (M.P.) 2 Section of Anatomic Pathology, ASST Mantova, Ospedale Carlo Poma, 46100 Mantova, Italy; [email protected] 3 Surgery and Experimental Medicine and Interdepartmental Center of Technology of Advanced Therapies (LTTA), Department of Morphology, University of Ferrara, 44121 Ferrara, Italy; [email protected] 4 Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy; [email protected] 5 Division of Pathology, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milano, Italy 6 Department of Biomedical, Surgical, and Dental Sciences, University of Milan, 20122 Milano, Italy * Correspondence: [email protected]; Tel.: +39-02-5032-0564; Fax: +39-02-5503-2860 Abstract: Background: GATA binding protein 3 (GATA3) expression is positively correlated with Citation: Querzoli, P.; Pedriali, M.; estrogen receptor (ER) expression, but its prognostic value as an independent factor remains unclear. Rinaldi, R.; Secchiero, P.; Rossi, P.G.; Thus, we undertook the current study to evaluate the expression of GATA3 and its prognostic value Kuhn, E. GATA3 as an Adjunct in a large series of breast carcinomas (BCs) with long-term follow-up. Methods: A total of 702 Prognostic Factor in Breast Cancer consecutive primary invasive BCs resected between 1989 and 1993 in our institution were arranged Patients with Less Aggressive in tissue microarrays, immunostained for ER, progesterone receptor (PR), ki-67, HER2, p53, and Disease: A Study with a Review of GATA3, and scored.
    [Show full text]
  • SHARP1 (BHLHE41) Mouse Monoclonal Antibody [Clone ID: OTI3H4] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA806354 SHARP1 (BHLHE41) Mouse Monoclonal Antibody [Clone ID: OTI3H4] Product data: Product Type: Primary Antibodies Clone Name: OTI3H4 Applications: IHC, WB Recommended Dilution: WB 1:2000, IHC 1:150 Reactivity: Human Host: Mouse Isotype: IgG1 Clonality: Monoclonal Immunogen: Human recombinant protein fragment corresponding to amino acids 1-297 of human BHLHE41(NP_110389) produced in E.coli. Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. Concentration: 1 mg/ml Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 50.3 kDa Gene Name: basic helix-loop-helix family member e41 Database Link: NP_110389 Entrez Gene 79365 Human Q9C0J9 Background: This gene encodes a basic helix-loop-helix protein expressed in various tissues. The encoded protein can interact with ARNTL or compete for E-box binding sites in the promoter of PER1 and repress CLOCK/ARNTL's transactivation of PER1. This gene is believed to be involved in the control of circadian rhythm and cell differentiation. Defects in this gene are associated with the short sleep phenotype. [provided by RefSeq, Feb 2014] This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 SHARP1 (BHLHE41) Mouse Monoclonal Antibody [Clone ID: OTI3H4] – TA806354 Synonyms: BHLHB3; DEC2; hDEC2; SHARP1 Protein Families: Transcription Factors Protein Pathways: Circadian rhythm - mammal Product images: HEK293T cells were transfected with the pCMV6- ENTRY control (Left lane) or pCMV6-ENTRY BHLHE41 ([RC206882], Right lane) cDNA for 48 hrs and lysed.
    [Show full text]
  • 2009 Riboclub Program
    RiboClub 2017 in association with the Swiss National Center of Competence in RNA & Disease. September 24-28 RNPs: the Good, the Bad and the Ugly Insights into RNA-protein complex assembly and function in health and disease Hotel et Villégiature Chéribourg 2603 Chemin du Parc Orford (Magog) Quebec, Canada Sunday, September 24th 15:00 – 18:00 Registration for early arrivals 18:00 – 19:30 Welcome reception 19:30 – 21:30 Opening dinner Monday, September 25th 08:00 – 08:45 Registration 08:45 – 08:55 Opening Notes and Announcements (Sherif Abou Elela) 08:55 – 09:10 Welcome Notes by Beat Nobs, Ph.D., Swiss Ambassador to Canada 09:10 – 09:15 Presentation of Keynote speaker (Oliver Mühlemann) 09:15 – 10:15 Keynote presentation From bench to clinical trial: microRNA 122 as an antiviral target for hepatitis C virus Peter Sarnow, Stanford University, Stanford 10:15 – 10:45 Coffee break Session 1: Non-coding RNA function Chair: Martin Jinek (Host: Benoit Chabot) 10:45 – 10:50 Introduction by Martin Jinek 10:50 – 11:05 Mbnl1-dependent mis-regulation and mis-splicing of a conserved myogenic lncRNA in myotonic dystrophy type 1 Pascal Chartrand, Universite de Montreal, Montreal 11:05 – 11:30 Non-canonical function of DGCR8 controls mESCs exit from pluripotency Constance Ciaudo, ETH Zurich, Zurich 11:30 – 11:45 microRNAs use different ways to regulate gene expression in animals Martin Simard, Universite Laval, Quebec 11:45 – 12:10 Structure, evolution and targeting of non coding RNAs Gabriele Varani, University of Washington, Seattle 12:10 – 12:35 Structural
    [Show full text]
  • A Core Transcriptional Network Composed of Pax2/8, Gata3 and Lim1 Regulates Key Players of Pro/Mesonephros Morphogenesis
    Developmental Biology 382 (2013) 555–566 Contents lists available at ScienceDirect Developmental Biology journal homepage: www.elsevier.com/locate/developmentalbiology Genomes and Developmental Control A core transcriptional network composed of Pax2/8, Gata3 and Lim1 regulates key players of pro/mesonephros morphogenesis Sami Kamel Boualia a, Yaned Gaitan a, Mathieu Tremblay a, Richa Sharma a, Julie Cardin b, Artur Kania b, Maxime Bouchard a,n a Goodman Cancer Research Centre and Department of Biochemistry, McGill University, 1160 Pine Ave. W., Montreal, Quebec, Canada H3A 1A3 b Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada H2W 1R7, Department of Anatomy and Cell Biology, Division of Experimental Medicine, McGill University, Montréal, Quebec, Canada, H3A 2B2 and Faculté de médecine, Université de Montréal, Montréal, Quebec, Canada, H3C 3J7. article info abstract Article history: Translating the developmental program encoded in the genome into cellular and morphogenetic Received 23 January 2013 functions requires the deployment of elaborate gene regulatory networks (GRNs). GRNs are especially Received in revised form crucial at the onset of organ development where a few regulatory signals establish the different 27 July 2013 programs required for tissue organization. In the renal system primordium (the pro/mesonephros), Accepted 30 July 2013 important regulators have been identified but their hierarchical and regulatory organization is still Available online 3 August 2013 elusive. Here, we have performed a detailed analysis of the GRN underlying mouse pro/mesonephros Keywords: development. We find that a core regulatory subcircuit composed of Pax2/8, Gata3 and Lim1 turns on a Kidney development deeper layer of transcriptional regulators while activating effector genes responsible for cell signaling Transcription and tissue organization.
    [Show full text]
  • Regulation of Drosophila Circadian Rhythms by Mirna Let-7 Is Mediated by a Regulatory Cycle
    ARTICLE Received 10 Jul 2014 | Accepted 10 Oct 2014 | Published 24 Nov 2014 DOI: 10.1038/ncomms6549 Regulation of Drosophila circadian rhythms by miRNA let-7 is mediated by a regulatory cycle Wenfeng Chen1,*, Zhenxing Liu1,*, Tianjiao Li1, Ruifeng Zhang1, Yongbo Xue1, Yang Zhong1, Weiwei Bai1, Dasen Zhou1 & Zhangwu Zhao1 MicroRNA-mediated post-transcriptional regulations are increasingly recognized as important components of the circadian rhythm. Here we identify microRNA let-7, part of the Drosophila let-7-Complex, as a regulator of circadian rhythms mediated by a circadian regulatory cycle. Overexpression of let-7 in clock neurons lengthens circadian period and its deletion attenuates the morning activity peak as well as molecular oscillation. Let-7 regulates the circadian rhythm via repression of CLOCKWORK ORANGE (CWO). Conversely, upregulated cwo in cwo-expressing cells can rescue the phenotype of let-7-Complex overexpression. Moreover, circadian prothoracicotropic hormone (PTTH) and CLOCK- regulated 20-OH ecdysteroid signalling contribute to the circadian expression of let-7 through the 20-OH ecdysteroid receptor. Thus, we find a regulatory cycle involving PTTH, a direct target of CLOCK, and PTTH-driven miRNA let-7. 1 Department of Entomology, College of Agronomy and Biotechnology, China Agricultural University, Beijing 100193, China. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to Z.Z. (email: [email protected]). NATURE COMMUNICATIONS | 5:5549 | DOI: 10.1038/ncomms6549 | www.nature.com/naturecommunications 1 & 2014 Macmillan Publishers Limited. All rights reserved. ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6549 lmost all animals display a wide range of circadian bantam-dependent regulation of Clk expression is required for rhythms in behaviour and physiology, such as locomotor circadian rhythm.
    [Show full text]
  • A Circadian Biomarker Associated with Breast Cancer in Young Women
    268 Cancer Epidemiology, Biomarkers & Prevention Period3 Structural Variation: A Circadian Biomarker Associated with Breast Cancer in Young Women Yong Zhu,1 Heather N. Brown,1 Yawei Zhang,1 Richard G. Stevens,2 and Tongzhang Zheng1 1Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut and 2University of Connecticut Health Center, Farmington, Connecticut Abstract Circadian disruption has been indicated as a risk factor for blood samples collected from a recently completed breast breast cancer in recent epidemiologic studies. A novel cancer case-control study in Connecticut. There were 389 finding in circadian biology is that genes responsible for Caucasian cases and 432 Caucasian controls included in our circadian rhythm also regulate many other biological path- analysis. We found that the variant Per3 genotype (heterozy- ways, including cell proliferation, cell cycle regulation, and gous + homozygous 5-repeat alleles) was associated with an apoptosis. Therefore, mutations in circadian genes could increased risk of breast cancer among premenopausal women conceivably result in deregulation of these processes and (odds ratio, 1.7; 95% confidence interval, 1.0-3.0). Our find- contribute to tumor development, and be markers for ing suggests that the circadian genes might be a novel panel susceptibility to human cancer. In this study, we investi- of potential biomarkers for breast cancer and worth further gated the association between an exonic length variation in a investigation. (Cancer Epidemiol Biomarkers Prev circadian gene, Period3 (Per3), and breast cancer risk using 2005;14(1):268–70) Introduction Genetic determinants have been found to be responsible for a Per2 gene can activate c-Myc signaling pathways leading to fundamental biological phenomenon: a universal 24-hour genomic instability and cell proliferation.
    [Show full text]
  • The for Report 07-08
    THE CENTER FOR INTEGRATIVE GENOMICS REPORT 07-08 www.unil.ch/cig Table of Contents INTRODUCTION 2 The CIG at a glance 2 The CIG Scientific Advisory Committee 3 Message from the Director 4 RESEARCH 6 Richard Benton Chemosensory perception in Drosophila: from genes to behaviour 8 Béatrice Desvergne Networking activity of PPARs during development and in adult metabolic homeostasis 10 Christian Fankhauser The effects of light on plant growth and development 12 Paul Franken Genetics and energetics of sleep homeostasis and circadian rhythms 14 Nouria Hernandez Mechanisms of basal and regulated RNA polymerase II and III transcription of ncRNA in mammalian cells 16 Winship Herr Regulation of cell proliferation 18 Henrik Kaessmann Mammalian evolutionary genomics 20 Sophie Martin Molecular mechanisms of cell polarization 22 Liliane Michalik Transcriptional control of tissue repair and angiogenesis 24 Alexandre Reymond Genome structure and expression 26 Andrzej Stasiak Functional transitions of DNA structure 28 Mehdi Tafti Genetics of sleep and the sleep EEG 30 Bernard Thorens Molecular and physiological analysis of energy homeostasis in health and disease 32 Walter Wahli The multifaceted roles of PPARs 34 Other groups at the Génopode 37 CORE FACILITIES 40 Lausanne DNA Array Facility (DAFL) 42 Protein Analysis Facility (PAF) 44 Core facilities associated with the CIG 46 EDUCATION 48 Courses and lectures given by CIG members 50 Doing a PhD at the CIG 52 Seminars and symposia 54 The CIG annual retreat 62 The CIG and the public 63 Artist in residence at the CIG 63 PEOPLE 64 1 Introduction The Center for IntegratiVE Genomics (CIG) at A glance The Center for Integrative Genomics (CIG) is the newest depart- ment of the Faculty of Biology and Medicine of the University of Lausanne (UNIL).
    [Show full text]
  • Targeting Glioblastoma Stem Cells Through Disruption of the Circadian Clock
    Published OnlineFirst August 27, 2019; DOI: 10.1158/2159-8290.CD-19-0215 RESEARCH ARTICLE Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock Zhen Dong1, Guoxin Zhang1, Meng Qu2, Ryan C. Gimple1,3, Qiulian Wu1, Zhixin Qiu1, Briana C. Prager1,3, Xiuxing Wang1, Leo J.Y. Kim1,3, Andrew R. Morton3, Deobrat Dixit1, Wenchao Zhou4, Haidong Huang4, Bin Li5, Zhe Zhu1, Shideng Bao4, Stephen C. Mack6, Lukas Chavez7, Steve A. Kay2, and Jeremy N. Rich1 Downloaded from cancerdiscovery.aacrjournals.org on September 24, 2021. © 2019 American Association for Cancer Research. Published OnlineFirst August 27, 2019; DOI: 10.1158/2159-8290.CD-19-0215 ABSTRACT Glioblastomas are highly lethal cancers, containing self-renewing glioblastoma stem cells (GSC). Here, we show that GSCs, differentiated glioblastoma cells (DGC), and nonmalignant brain cultures all displayed robust circadian rhythms, yet GSCs alone displayed exquisite dependence on core clock transcription factors, BMAL1 and CLOCK, for optimal cell growth. Downregulation of BMAL1 or CLOCK in GSCs induced cell-cycle arrest and apoptosis. Chromatin immu- noprecipitation revealed that BMAL1 preferentially bound metabolic genes and was associated with active chromatin regions in GSCs compared with neural stem cells. Targeting BMAL1 or CLOCK attenu- ated mitochondrial metabolic function and reduced expression of tricarboxylic acid cycle enzymes. Small-molecule agonists of two independent BMAL1–CLOCK negative regulators, the cryptochromes and REV-ERBs, downregulated stem cell factors and reduced GSC growth. Combination of cryp- tochrome and REV-ERB agonists induced synergistic antitumor effi cacy. Collectively, these fi ndings show that GSCs co-opt circadian regulators beyond canonical circadian circuitry to promote stemness maintenance and metabolism, offering novel therapeutic paradigms.
    [Show full text]
  • A Wheel of Time: the Circadian Clock, Nuclear Receptors, and Physiology
    Downloaded from genesdev.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press PERSPECTIVE A wheel of time: the circadian clock, nuclear receptors, and physiology Xiaoyong Yang1 Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut 06519, USA It is a long-standing view that the circadian clock func- The rhythmic production and circulation of many tions to proactively align internal physiology with the hormones and metabolites within the endocrine system 24-h rotation of the earth. Recent studies, including one is instrumental in regulating regular physiological pro- by Schmutz and colleagues (pp. 345–357) in the February cesses such as reproduction, blood pressure, and metabo- 15, 2010, issue of Genes & Development, delineate strik- lism. Levels of circulating estrogen and progesterone ingly complex connections between molecular clocks and fluctuate with the menstrual cycle, which in turn affect nuclear receptor signaling pathways, implying the exis- circadian rhythms in women (Shechter and Boivin 2010). tence of a large-scale circadian regulatory network co- In parallel with a diurnal rhythm in circulating adrenocor- ordinating a diverse array of physiological processes to ticotropic hormone, secretion of glucocorticoids and aldo- maintain dynamic homeostasis. sterone from the adrenal gland rises before awakening (Weitzman 1976). Glucocorticoids boost energy produc- tion, and aldosterone increases blood pressure, together gearing up the body for the activity phase. Similarly, Light from the sun sustains life on earth. The 24-h plasma levels of thyroid-stimulating hormone and triiodo- rotation of the earth exposes a vast number of plants thyronine have a synchronous diurnal rhythm (Russell and animals to the light/dark cycle.
    [Show full text]